Qianqian Di
Guangdong Provincial Key Laboratory Of Infection Immunity And Inflammation
Shenzhen, 518060, China
Shenzhen, 518060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Corylifol a alleviates lipopolysaccharide-induced inflammation by targeting and inhibiting IκBα phosphorylation.
Journal: International immunopharmacology
Published: April 09, 2026
Spautin-1 inhibits osteoclast differentiation and attenuates bone loss by blocking USP10/JIP1-mediated JNK pathway.
Journal: Biochemical pharmacology
Published: February 22, 2026
The USP43/RNF2 axis negatively regulates antiviral innate immunity by promoting TBK1 ubiquitination and degradation.
Journal: Cell death and differentiation
Published: September 17, 2024
Kumujan B suppresses TNF-α-induced inflammatory response and alleviates experimental colitis in mice.
Journal: Frontiers in pharmacology
Published: May 07, 2024
USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression.
Journal: Translational oncology
Published: March 15, 2023
A new acid isolated from V. negundo L. inhibits NLRP3 inflammasome activation and protects against inflammatory diseases.
Journal: Frontiers in immunology
Published: February 26, 2023
USP39 Regulates NF-κB-Mediated Inflammatory Responses through Deubiquitinating K48-Linked IκBα.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 15, 2022
HDAC11 negatively regulates antifungal immunity by inhibiting Nos2 expression via binding with transcriptional repressor STAT3.
Journal: Redox biology
Published: August 10, 2022
USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy.
Journal: Autophagy
Published: July 28, 2022
Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3.
Journal: Frontiers in immunology
Published: January 12, 2022
Succinate Is a Natural Suppressor of Antiviral Immune Response by Targeting MAVS.
Journal: Frontiers in immunology
Published: November 16, 2021
Last Updated: 09/26/2026